Literature DB >> 9221989

The pathophysiology of ovarian hyperstimulation syndrome--views and ideas.

U Elchalal1, J G Schenker.   

Abstract

Ovarian hyperstimulation syndrome (OHSS) is a serious complication affecting ovulation induction. Its most severe manifestation takes the form of massive ovarian enlargement and multiple cysts, haemoconcentration and third-space accumulation of fluid. The full-blown clinical syndrome may be complicated by renal failure and oliguria, hypovolaemic shock, thromboembolic episodes, adult respiratory distress syndrome (ARDS), and death. Although the pathophysiology of this syndrome has not been completely elucidated, it seems likely that the increased capillary permeability triggered by the release of vasoactive substance secreted by the ovaries under human chorionic gonadotrophin (HCG) stimulation plays a key role in this syndrome. Several factors such as histamine, serotonin, prostaglandins, prolactin, and a variety of other substances have been implicated in this process in the past. At present, factors belonging to the renin-angiotensin system, cytokines including the interleukins, tumour necrosis factor alpha, endothelin-1 and vascular endothelial growth factor (VEGF) are thought to be involved in triggering increased vascular permeability after ovulation induction treatment. This manuscript summarizes the current knowledge of the pathophysiology of ovarian hyperstimulation syndrome with emphasis on the correlation of the various factors with the clinical phenomena of this iatrogenic syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9221989     DOI: 10.1093/humrep/12.6.1129

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  36 in total

Review 1.  The empty follicle syndrome.

Authors:  A Kourtis; D Rousso; D Panidis
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

Review 2.  Understanding ovarian hyperstimulation syndrome.

Authors:  Anne Delbaere; Guillaume Smits; Anne De Leener; Sabine Costagliola; Gilbert Vassart
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

3.  Internal jugular vein thrombosis and ovarian hyperstimulation syndrome.

Authors:  D M Raw; M C Collins
Journal:  J R Soc Med       Date:  2007-07       Impact factor: 5.344

4.  A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.

Authors:  Yanett Anaya; Douglas A Mata; Joseph Letourneau; Hakan Cakmak; Marcelle I Cedars; Mitchell P Rosen
Journal:  J Assist Reprod Genet       Date:  2017-10-30       Impact factor: 3.412

5.  Could pretreatment with oral contraceptives before pituitary down regulation reduce the incidence of ovarian hyperstimulation syndrome in the IVF/ICSI procedure?

Authors:  Lan Wang; Yiqing Zhao; Xiyuan Dong; Kai Huang; Rui Wang; Licheng Ji; Ya Wang; Hanwang Zhang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 6.  Mini puberty and its interpretation.

Authors:  Selim Kurtoğlu; Osman Baştuğ
Journal:  Turk Pediatri Ars       Date:  2014-09-01

7.  GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation.

Authors:  Kutluk Oktay; Ilgın Türkçüoğlu; Kenny A Rodriguez-Wallberg
Journal:  Reprod Biomed Online       Date:  2010-03-06       Impact factor: 3.828

8.  Recombinant human thyrotropin use resulting in ovarian hyperstimulation: an unusual side effect.

Authors:  Tanvir Rizvi; Patrice K Rehm
Journal:  Eur Thyroid J       Date:  2014-06-07

9.  Association between peak estradiol levels and ovarian torsion among symptomatic patients receiving gonadotropin treatment.

Authors:  Phillip A Romanski; Alexander Melamed; Kevin M Elias; Aleksandar K Stanic; Raymond M Anchan
Journal:  J Assist Reprod Genet       Date:  2017-03-15       Impact factor: 3.412

10.  A case of severe ovarian hyperstimulation syndrome.

Authors:  Moushumi Lodh; Jheelam Mukhopadhyay; Vikas Sharma
Journal:  Indian J Clin Biochem       Date:  2013-10-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.